Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
Amirah Al Idrus
New insight into why malaria drugs work against some cancers
Friday, November 16, 2018
Antimalarial drugs known as chloroquines play a role in inhibiting cancer cell growth by targeting the enzyme PPT1, researchers discovered.
New discoveries in ALS and malaria—News of Note
Monday, July 16, 2018
The week’s biotech news included a mutation-targeting treatment for ALS and a malaria vaccine targeting a transmission protein.
FDA AdComm backs GSK’s 1-shot malaria therapy
Monday, July 16, 2018
GlaxoSmithKline is close to ending a six-decade drought in relapse-preventing therapies for Plasmodium vivax—one of the most common forms of malaria.
Swedish developer Modus brings in $15M to fund sickle cell drug
Friday, July 13, 2018
Modus Therapeutics raised over 140 million Swedish krona, or about $15.7 million, to advance clinical studies of sevuparin in sickle cell disease.
PATH partners with SD Biosensor for malaria treatment diagnostic
Thursday, June 21, 2018
PATH partnered with SD Biosensor to develop an in vitro diagnostic to screen out patients that may be harmed by common malaria treatments.
Gates Foundation’s $100M-a-year nonprofit biotech takes flight
Nick Paul Taylor
Friday, June 8, 2018
The Gates Medical Research Institute will turn drug industry expertise on diseases that kill millions annually in low- and middle-income countries.
MIT develops cheap, build-your-own paper diagnostic tests
Thursday, May 17, 2018
A modular set of blocks from MIT can be snapped together to build an array of medical diagnostics, enabling smaller labs to customize their own tests.
New discoveries in ALS and bladder cancer—News of Note
Monday, March 26, 2018
The past week saw the discovery of a genetic mutation that disrupts nerve signaling in ALS and the development of a noninvasive bladder cancer test.
New discoveries in male contraception and malaria—News of Note
Monday, March 19, 2018
Biotech developments over the past week include promising data from a human trial of male contraception and a new strategy to protect against malaria.